News
One practice’s experience with obesity treatment
WASHINGTON – “We have heard about a lot of really interesting new things in therapy, but the reality is that they are just not economically viable...
News
Disparities found in access to medication treatment for OUDs
Medicaid recipients living in counties with fewer black and Hispanic residents – and lower poverty rates – are more likely to receive OUD...
News
FDA approves topical anticholinergic for primary axillary hyperhidrosis
Glycopyrronium, approved for children and adults ages 9 years and older, comes in a single-use cloth wipe applied once a day to both axillae.
News
Screen sooner and more often for those with family history of CRC
A family history of colorectal cancer is associated with risk of colorectal cancer, and screening guidelines should be adjusted accordingly.
News
Anthrax vaccine recommendations updated in the event of a wide-area release
The committee recommended three updates to its current policy of anthrax vaccination.
News
Bullae associated with pediatric human parvovirus B19 infection
Parvovirus is generally associated with a “slapped-cheek” appearance, with the appearance of bullae rare.
News
Preterm infant GER is a normal phenomenon
Traditional and pharmacologic interventions do not appear to work. Patience may be the best medicine.
News
Pancreatic cancer has a pancreatopathy distinct from type 2 diabetes
WASHINGTON – The relationship between pancreatic cancer and diabetes is complex, but certain pathological markers differentiate them.
News
FDA approves pembrolizumab for relapsed/refractory PMBCL
The FDA granted accelerated approval based on results from the KEYNOTE-170 trial.
Video
Web portal does not reduce phone encounters or office visits for IBD patients
WASHINGTON - The web portal MyChart allows patients to send messages to their providers, but does not improve patient outcomes.
News
Multiple therapies for NAFLD and NASH are now in phase 3 clinical trials
WASHINGTON – The trials are tricky, but these much-needed therapies may get conditional approval through reduction of liver inflammation and...
News
Barrett’s segment length, low-grade dysplasia tied to increased risk of neoplastic progression
A Dutch study found that age at baseline endoscopy, length of Barrett’s segment, and low-grade dysplasia were significant predictors of neoplastic...
News
FDA approves Olumiant for treatment of rheumatoid arthritis
Lilly said it expects the JAK inhibitor to be available in the second quarter of 2018.